NEW YORK ( TheStreet) -- Omnicare Inc (NYSE: OCR) hit a new 52-week low Tuesday as it is currently trading at $21.80, below its previous 52-week low of $22.15 with five million shares traded as of 2:26 p.m. ET. Average volume has been 1.7 million shares over the past 30 days.

Omnicare has a market cap of $2.9 billion and is part of the services sector and wholesale industry. Shares are down 3.2% year to date as of the close of trading on Monday.

Omnicare, Inc. provides pharmaceuticals, and related pharmacy and ancillary services to long-term healthcare institutions.
  • Practice your OCR trading strategies and win cash in our stock game.

TheStreet Ratings rates Omnicare as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. You can view the full Omnicare Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.